Stock CDMO AVID BIOSERVICES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Avid Bioservices, Inc.

Equities

CDMO

US05368M1062

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
7.35 USD +0.41% Intraday chart for Avid Bioservices, Inc. +15.02% +13.08%
Apr. 24 Avid Bioservices, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Apr. 19 North American Morning Briefing : Stock Futures -2- DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avid Bioservices: Fiscal Q3 Earnings Snapshot
AQ
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
PR
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
AQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
BU
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
BU
Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
BU
The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
BU
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
BU
CDMO LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMO
BU
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
AQ
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
AQ
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
AQ
Avid Bioservices: Fiscal Q2 Earnings Snapshot
AQ
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
AQ
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
AQ
Avid Bioservices Partners with California Institute for Regenerative Medicine to Provide CDMO Services for Cell and Gene Therapy Programs
AQ
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CDMO Stock
  4. News Avid Bioservices, Inc.
  5. Press Releases